Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07174869 · ClinicalTrials.gov registry record

A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population

A clinical trial of Mild Cognitive Impairment (MCI) and Mild Alzheimer Disease, sponsored by Indivi.

Recruiting
Registry status
55
Enrollment target
1
Study location

NCT07174869 is a study of Mild Cognitive Impairment (MCI) and Mild Alzheimer Disease that is actively recruiting participants, run by Indivi. The registered enrollment target is 55 participants, below the 157-participant average among 19 other Mild Cognitive Impairment (MCI) trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07174869, a study of Mild Cognitive Impairment (MCI) and Mild Alzheimer Disease, is actively recruiting participants, sponsored by Indivi.

RECRUITING
Registry status
55 participants
Enrollment target
1
Study location

Study Summary

The goal of this observational study is to evaluate the functionality and usability of Indivi mobile application-based cognitive activities in people with mild cognitive impairment/mild Alzheimer's disease (PwMCI/AD) and healthy controls (HC). This application uses a dynamic difficulty adjustment (DDA) system that customizes the level of the cognitive activities to each user. The main questions it aims to answer are: * Does the DDA system reach a stable difficulty level at the same rate for both PwMCI/AD and HC? * Is the stable difficulty level reached by the DDA system different for PwMCI/AD compared to HC? Researchers will also compare cognitive activities results and other aspects of the mobile application's performance to see if the application can validly distinguish between the two groups. Participants will use the Indivi mobile application, with its embedded DDA system, for a 6-week period.

Conditions Studied

Mild Cognitive Impairment (MCI) Mild Alzheimer Disease

Study Locations (1)

Massachusetts

  • Boston University School of Medicine - Boston

Trial Details

FieldValue
Enrollment Target 55 participants
Start Date 2025-09
Est. Completion 2026-06

Sponsor

Indivi

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07174869

The ClinicalTrials.gov registry entry for NCT07174869 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 157-participant average among 19 other Mild Cognitive Impairment (MCI) trials with a reported enrollment target (65% lower). The listed sponsor is Indivi, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Mild Cognitive Impairment (MCI) appearing as the primary indexed condition, and to 0 interventions.

NCT07174869 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07174869 about?

NCT07174869 is a clinical study titled "A Study To Assess The Feasibility Of Indivi Mobile Application In Monitoring Cognitive Performance In Aging Population". The goal of this observational study is to evaluate the functionality and usability of Indivi mobile application-based cognitive activities in people with mild cognitive impairment/mild Alzheimer's disease (PwMCI/AD) and healthy controls (HC). This application uses a dynamic difficulty adjustment (D...

What is the current status of trial NCT07174869?

This trial is currently recruiting. The enrollment target is 55 participants. The study started on 2025-09. Estimated completion is 2026-06.

What conditions does trial NCT07174869 study?

This clinical trial studies the following conditions: Mild Cognitive Impairment (MCI), Mild Alzheimer Disease.

Who is sponsoring clinical trial NCT07174869?

This trial is sponsored by Indivi, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07174869 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Mild Cognitive Impairment (MCI)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Mild Cognitive Impairment (MCI)

All registered trials for this condition

Mild Alzheimer Disease

All registered trials for this condition

Massachusetts

All trials with a study site in Massachusetts

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.